language_icon
EN
HI

Beryl Drugs Share price

BERLDRG

25.04

1.19 (4.99%)
Last updated on 15 Apr, 2026 | 14:06 IST
Today's High

25.04

Today's Low

23.50

52 Week Low

15.92

52 Week High

30.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Beryl Drugs Chart

Beryl Drugs Share Key Metrics

Volume
5519.00
Market Cap
12.10 CR
LTQ@LTP
1@25.04
ATP
24.78
Var Margin
100 %
Circuit Range
22.66-25.04
Delivery %
100 %
Value
1.37 L
ASM/GSM
No
Market Lot
1

Summary

At 15 Apr, 2026 | 14:06, Beryl Drugs share price stands at ₹25.04, showing a 1.19% 4.99 for the day. The stock’s intraday movement has stayed between ₹23.50 and ₹25.04, while on a 52-week basis it has fluctuated from ₹15.92 to ₹30.00.
In terms of trading activity, Beryl Drugs has recorded a volume of 5519 shares, with a market capitalisation of ₹5071700. The stock’s Average Traded Price (ATP) stands at ₹2478, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,2504. The stock operates within a circuit range of ₹22.66-25.04, with a Value of ₹1.37 L. The Delivery Percentage for the day is 100%. Additionally, Beryl Drugs currently falls under the No framework, and trades with a market lot size of 1.

Beryl Drugs Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

62.91

Sector P/B

3.4

Sec. Div. Yield

0.57

Beryl Drugs Resistance and Support

Pivot 23.69

Resistance

First Resistance

24.02

Second Resistance

24.18

Third Resistance

24.51

Support

First Support

23.53

Second Support

23.2

Third Support

23.04

Beryl Drugs Futures & Options

Data Not Found

Beryl Drugs Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

27.48%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

72.52%

Others

0%

Total Promoters
MAR '26
27.48%

Beryl Drugs Corporate Actions

DateAgenda
2026-04-01Notice of EGM & Others
2026-02-09Quarterly Results
2026-01-03Others
2025-11-13Quarterly Results
2025-09-02A.G.M.
2025-08-07Quarterly Results
2025-05-30Audited Results
2025-02-08Quarterly Results

Beryl Drugs News

Beryl Drugs Ltd - 524606 - FIXES RECORD DATE FOR THE PURPOSE OF EXTRA ORDINARY GENERAL MEETING OF THE COMPANY

Beryl Drugs set May 4, 2026, as the record date for shareholders to be eligible for voting at its Extra-Ordinary General Meeting (EOGM) on May 11, 2026. This allows eligible shareholders to participate via remote e-voting or in person.
Apr 01 2026 17:04:00

Beryl Drugs Ltd - 524606 - EGM ON 11TH MAY, 2026 AT 11:00 A.M

Beryl Drugs will convene an EOGM on May 11, 2026, to approve the regularization of Mr. Shailendra Pathak as Whole Time Director and Mrs. Neha Sharda as Independent Director. Shareholders will also vote on a material related party transaction with Aminova Infusions P. Ltd. worth ₹5 crore for product distribution, which is expected to boost company turnover and profits by accessing new markets.
Apr 01 2026 16:04:00
Read More

About Beryl Drugs

NSE : 0  
BSE : 524606  
ISIN : INE415H01017  

Beryl Drugs Management

NamePosition
Mr. Sudhir Sethi Chairman & Director
Mr. Sanjay Sethi Managing Director
View More

Beryl Drugs FAQs

The Buying Price of Beryl Drugs share is 25.04 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Beryl Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.

To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 62.91 & 3.4 with sector averages, along with growth rates and financial metrics.

The Market Cap of Beryl Drugs is 12.10 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Beryl Drugs share price is 30.00 & 15.92. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Beryl Drugs belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost